Search Results - "Robertson, Louise J"

Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy by Dawson, Ruby E., Nieto Guil, Alvaro F., Robertson, Louise J., Piltz, Sandra G., Hughes, James N., Thomas, Paul Q.

“…Mutations in the GAP activity toward RAGs 1 (GATOR1) complex genes (DEPDC5, NPRL2 and NPRL3) have been associated with focal epilepsy and focal cortical…”
Get full text

Investigating the potential of X chromosome shredding for mouse genetic biocontrol by Bunting, Mark D., Godahewa, Gelshan I., McPherson, Nicole O., Robertson, Louise J., Gierus, Luke, Piltz, Sandra G., Edwards, Owain, Tizard, Mark, Thomas, Paul Q.

“…CRISPR-Cas9 technology has facilitated development of strategies that can potentially provide more humane and effective methods to control invasive vertebrate…”
Get full text

User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing by Jing, Min, Bond, Raymond, Robertson, Louise J., Moore, Julie, Kowalczyk, Amanda, Price, Ruth, Burns, William, Nesbit, M. Andrew, McLaughlin, James, Moore, Tara

“…Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by…”
Get full text

User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test by Jing, Min, Bond, Raymond, Robertson, Louise J., Moore, Julie, Kowalczyk, Amanda, Price, Ruth, Burns, William, Nesbit, M. Andrew, McLaughlin, James, Moore, Tara

“…The urgent need to scale up testing capacity during the COVID-19 pandemic has prompted the rapid development of point-of-care diagnostic tools such as lateral…”
Get full text

Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months by Robertson, Louise J, Moore, Julie S, Blighe, Kevin, Ng, Kok Yew, Quinn, Nigel, Jennings, Fergal, Warnock, Gary, Sharpe, Peter, Clarke, Mark, Maguire, Kathryn, Rainey, Sharon, Price, Ruth K, Burns, William P, Kowalczyk, Amanda M, Awuah, Agnes, McNamee, Sara E, Wallace, Gayle E, Hunter, David, Sager, Steve, Chao Shern, Connie, Nesbit, M Andrew, McLaughlin, James A D, Moore, Tara

“…ObjectiveTo evaluate the dynamics and longevity of the humoral immune response to SARS-CoV-2 infection and assess the performance of professional use of the…”
Get full text

IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study by Robertson, Louise J., Price, Ruth, Moore, Julie S., Curry, Grace, Farnan, John, Black, Amy, Blighe, Kevin, Nesbit, M. Andrew, McLaughlin, James A.D., Moore, Tara

“…This study evaluates spike protein IgG antibody response following Oxford-AstraZeneca COVID-19 vaccination using the AbC-19™ lateral flow device. Plasma…”
Get full text

Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease by Christie, Kathleen A., Robertson, Louise J., Conway, Caroline, Blighe, Kevin, DeDionisio, Larry A., Chao-Shern, Connie, Kowalczyk, Amanda M., Marshall, John, Turnbull, Doug, Nesbit, M. Andrew, Moore, C.B. Tara

“…CRISPR-Cas9 provides a tool to treat autosomal dominant disease by non-homologous end joining (NHEJ) gene disruption of the mutant allele. In order to…”
Get full text